Chagas disease, caused by the parasite Trypanosoma cruzi, is a serious health problem in
Latin America and is an emerging disease in non-endemic countries. In recent decades, the …

Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in Latin America
and affects ca. 10 million people worldwide. About 30% of Chagas disease patients develop …

Infection with the protozoan parasite Trypanosoma cruzi, the agent of Chagas disease, is
characterised by a variable clinical course–from symptomless cases to severe chronic …

The inflammatory response that follows the infection with Trypanosoma cruzi is essential for
host resistance to infection but is also responsible for the diverse pathology observed in …

Chagas heart disease is an inflammatory cardiomyopathy that develops in approximately
one-third of individuals infected with the protozoan parasite Trypanosoma cruzi. Since the …

Chagas disease is caused by infection with the protozoan Trypanosoma cruzi and affects
over 8 million people worldwide. In spite of a powerful innate and adaptive immune …

Background Chronic Chagas cardiomyopathy (CCC), a life-threatening inflammatory dilated
cardiomyopathy, affects 30% of the approximately 8 million patients infected by …

Chagas disease, a neglected disease caused by the protozoan Trypanosoma cruzi, is
endemic in 21 Latin American countries, affecting 6–8 million people. Increasing numbers of …

The pathogenesis of myocarditis during Trypanosoma cruzi infection is poorly understood.
We investigated the role played by chemokine receptor 5 (CCR5) in the influx of T cells to …

As a consequence of infection by Trypanosoma cruzi, 30% of victims may develop chronic
Chagas disease, which presents a spectrum of pathology including cardiomyopathy …